ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
0.335
-0.0075
(-2.19%)
Closed 21 December 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.335
Bid
0.335
Offer
0.355
Volume
1,939,246
0.335 Day's Range 0.3525
0.23 52 Week Range 0.485
Market Cap
Previous Close
0.3425
Open
0.35
Last Trade
90
@
0.34
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,192,125
Shares Outstanding
879,089,453
Dividend Yield
-
PE Ratio
-6.79
Earnings Per Share (EPS)
-0.05
Revenue
-
Net Profit
-42.72M

About Immutep Limited

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Sydney, New South Wales, Aus
Founded
-
Immutep Limited is listed in the Biological Pds,ex Diagnstics sector of the Australian Stock Exchange with ticker IMM. The last closing price for Immutep was AUD0.34. Over the last year, Immutep shares have traded in a share price range of AUD 0.23 to AUD 0.485.

Immutep currently has 879,089,453 shares in issue. The market capitalisation of Immutep is AUD301.09 million. Immutep has a price to earnings ratio (PE ratio) of -6.79.

IMM Latest News

Immutep Has Successful Type C Meeting With FDA

By Chris Wack Immutep Ltd. said Friday it had a successful Type C meeting with the U.S. Food and Drug Administration regarding late-stage clinical development plans for its first-in-class soluble...

Immutep Gets Fast Track Designation for Eftilagimod Alpha Cancer Treatment

By Chris Wack Immutep Ltd. said Tuesday that the U.S. Food and Drug Administration granted fast track designation to eftilagimod alpha IMP321 in combination with pembrolizumab for the treatment of...

Immutep in Collaboration, Supply Agreement With Merck KGaA

By Chris Wack Immutep Limited is in a new collaboration and supply agreement with Merck KGaA, Darmstadt, Germany, for a Phase I/IIa clinical trial in patients with solid tumors. The biotechnology...

Immutep Says Interim Phase II TACTI-002 Data Positive

By Michael Dabaie Immutep Ltd. said interim data was positive from its ongoing Phase II TACTI-002 study. ADRs were down 1% to $3.00 premarket. The data relates to use of the company's lead...

Immtech to be Listed on OTC Market

NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading its common stock on the Pink OTC Markets quotation...

Immtech to Reorganize Research and Development Operations

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its R&D operations. This restructuring will direct...

Immtech Announces Investment in China

NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in Gold Avenue Ltd., a privately-held Hong Kong company...

Immtech Receives Listing Determination Letter

NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company received notice from the NYSE Amex LLC (the...

Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance

NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming...

Immtech To Reschedule Quarterly Conference Call

NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM) announced today that the Company will postpone the quarterly update conference call scheduled...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.04-10.66666666670.3750.3850.3331227070.36036204DE
40.039.836065573770.3050.3850.28531061590.33013655DE
12000.3350.3850.2731921250.31640369DE
26-0.065-16.250.40.440.2343521300.33048896DE
52-0.01-2.898550724640.3450.4850.2331152540.35241647DE
156-0.14-29.47368421050.4750.520.22518594250.34213065DE
2600.085340.250.7250.120973110.36718835DE

IMM - Frequently Asked Questions (FAQ)

What is the current Immutep share price?
The current share price of Immutep is AUD 0.335
How many Immutep shares are in issue?
Immutep has 879,089,453 shares in issue
What is the market cap of Immutep?
The market capitalisation of Immutep is AUD 301.09M
What is the 1 year trading range for Immutep share price?
Immutep has traded in the range of AUD 0.23 to AUD 0.485 during the past year
What is the PE ratio of Immutep?
The price to earnings ratio of Immutep is -6.79
What is the reporting currency for Immutep?
Immutep reports financial results in AUD
What is the latest annual profit for Immutep?
The latest annual profit of Immutep is AUD -42.72M
What is the registered address of Immutep?
The registered address for Immutep is LEVEL 12, 95 PITT STREET, SYDNEY, NEW SOUTH WALES, 2000
What is the Immutep website address?
The website address for Immutep is www.immutep.com
Which industry sector does Immutep operate in?
Immutep operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ODEOOdessa Minerals Ltd
AUD 0.002
(100.00%)
500k
LM1Leeuwin Metals Ltd
AUD 0.10
(66.67%)
468.95k
RADORadiopharm Theranostics Ltd
AUD 0.008
(60.00%)
200k
PKOPeako Limited
AUD 0.003
(50.00%)
166.67k
ENVOEnova Mining Ltd
AUD 0.003
(50.00%)
250k
JAYJayride Group Limited
AUD 0.003
(-40.00%)
5.13M
CZNCorazon Mining Ltd
AUD 0.002
(-33.33%)
7.71M
1AIOAlgorae Pharmaceuticals Ltd
AUD 0.002
(-33.33%)
1.55M
GTRGTI Energy Ltd
AUD 0.003
(-25.00%)
5.68M
TTITraffic Technologies Ltd
AUD 0.003
(-25.00%)
4.6M
VAUVault Minerals Ltd
AUD 0.325
(-1.52%)
52.89M
EVNEvolution Mining Ltd
AUD 4.80
(0.00%)
38.65M
RSGResolute Mining Limited
AUD 0.4025
(0.63%)
37.61M
SYASayona Mining Limited
AUD 0.0255
(4.08%)
36.86M
MSBMesoblast Limited
AUD 2.40
(-21.31%)
34.45M

Discussion

View Full Feed
ITYS ITYS 5 minutes ago
THIS WAS COMPANY'S UPDATE it last financials :-)
Basically a go screw the open market investors :-)

Note 12 – Subsequent Events Management evaluated all additional events through the date the consolidated financial statements were available to be issued. Based upon this review,
GEVI
dirkv dirkv 5 minutes ago
wowww

TAOP: Pre-Market Share Volume
48,154,804
Pre-Market High $1.05
dirkv dirkv 5 minutes ago
wowww

TAOP: Pre-Market Share Volume
48,154,804
Pre-Market High $1.05
flipper44 flipper44 5 minutes ago
That’s one possible explanation.
NWBO
dewophile dewophile 5 minutes ago
The market clearly thinks the RSV drug is going to fail. The bear case is basically that other drugs with positive challenge data failed when tested in real world scenarios, including Zeli in standard risk adults. The only one that nominally succeeded - ziresovir, Ark bio's fusion inhibitor - had a
JNJ PFE
TKS PARTY TKS PARTY 5 minutes ago
Mattordaddy, literally laughed out loud, multiple secret blending and distribution locations, and sworn to secrecy so not one shareholder actually knows. We wonder why are stock is less than 80 cents. No distribution for California, not one announced Dynamo contract in nearly 4 years and the PR from
CBRF
stocktowatch stocktowatch 5 minutes ago
$ILLR Triller Group shared a bold strategic vision and exciting updates during our Investor Day, highlighting innovation, growth, and transformation across our ecosystem.
https://x.com/triller_IR/status/1870108542126174637
ILLR
stealofadeal stealofadeal 5 minutes ago
$GEVI Some people have no purpose and nothing better to do but stalk a GEVI board. Dude got fired by Steve Conboy and easy to know who it is here. GEVI is solid and holding for the big push.
GEVI
chemist72 chemist72 6 minutes ago
I have 2 primary examples of PRs that were completely misleading and primarily fraudulent.

I don't know how we can prove that those PRs caused us to buy more shares of MVNT, but they certainly encouraged me to do so. I will try to search through MVNT's posts on X over the weekend. I w
MVNT
Curt D Curt D 6 minutes ago
I'm going to begin correcting everyone's English because what I'm seeing is absolutely intolerable

You won't make any friends. English is a second language to some of the posters here. Can you speak multiple languages?
RDAR
al44 al44 6 minutes ago
Congressional dirty dealing is now on full display

By Anony Mee

The proposed language of the next continuing resolution seems to be back on the drawing board. One of the big questions, though, about the 1,547-page monstrosity that just died in the House is how we can ho
quester614 quester614 6 minutes ago
You act like YOU have nothing to do with that. After 4 years of BS AND CHEAP BASELESS INSULTS of others. You are truly clueless.
XERI
Rambo Rell Rambo Rell 6 minutes ago
$ILLR 🚀 Big moves ahead! Triller Group just unveiled an ambitious vision and exciting updates during their Investor Day. With innovation and growth in the spotlight, this could be a game-changer for the creator economy. 🌟

🔗 Read more: https://trillercorp.com/tr
ILLR
Gizzer211 Gizzer211 6 minutes ago
UMAV news
UMAV
Rambo Rell Rambo Rell 7 minutes ago
$ILLR 🚀 Big moves ahead! Triller Group just unveiled an ambitious vision and exciting updates during their Investor Day. With innovation and growth in the spotlight, this could be a game-changer for the creator economy. 🌟

🔗 Read more: https://trillercorp.com/tr
ILLR
WeTheMarket WeTheMarket 7 minutes ago
Repost from Stocktwits board, courtesy of Gio_F.

One of the first places where the final 45V rule will likely appear is here: https://home.treasury.gov/news/press-releases Last indication is still "before year end". To consider: last year's draft 45V rule was released on Friday, Dece
NKLA
learningcurve2020 learningcurve2020 7 minutes ago
Almost brought the entire market down.  LOL
NWBO
flipper44 flipper44 7 minutes ago
It could be an accounting error, but you are unnecessarily distorting what I am saying. I am saying why sell cheap shares if a better source of funding became available? You just attack the person and distort the question.
NWBO
Alley-oop Alley-oop 7 minutes ago
No. I just provided the general process for fins.
GRLT
Smartypants2 Smartypants2 7 minutes ago
I was obviously referring to KZ's use of ALL-CAPS in general, you dimwit! The fact that he didn't capitalize one word in one particular post is irrelevant.
XERI
gawti88 gawti88 7 minutes ago
haha, I got big commission cheque coming next week. Deploying gonna buy 300k+ more.
CEOS
BurgerKing82 BurgerKing82 7 minutes ago
This looks ready to pop
WORX
RIGATONI RIGATONI 7 minutes ago
Refresher > > >



https://northerndynastyminerals.com/pebble-project/project-overview/


The Pebble Project is located in southwest Alaska. Northern Dynasty is 100% owner of the Pebble Partnership, which is advancing the world-class Pebble deposit t
Golden Cross Golden Cross 7 minutes ago
📰 News Out 📰 Triller Group Inc. Unveils Bold Vision and Exciting Business Updates During Investor Day
https://www.benzinga.com/pressreleases/24/12/g42616393/triller-group-inc-unveils-bold-vision-and-exciting-business-updates-during-investor-day

$ILLR
ILLR

Your Recent History

Delayed Upgrade Clock